v3.25.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Convertible Warrants
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2023 $ 56     $ 720,899 $ 218,575 $ (14,187) $ 925,343
Beginning balance (in shares) at Dec. 31, 2023 56,467,623            
Net loss         (78,296)   (78,296)
Other comprehensive income           8,697 8,697
Stock based compensation       845     845
Cash dividend         (1,131)   (1,131)
Stock grants - vesting of restricted stock units $ 1           1
Stock grants - vesting of restricted stock units (in shares) 97,780            
Stock issued, value $ 11 $ 138,462   35,307     35,318
Stock issued (in shares) 11,308,676 44,301          
Issuance of warrants     $ 54,219       54,219
Issuance of warrants (in shares)     6        
Issuance costs   $ (8,210) $ (3,215) (2,094)     (13,519)
Repurchase of shares from restricted shares vesting       (142)     (142)
Repurchase of shares from restricted shares vesting (in shares) (18,995)            
Ending balance at Sep. 30, 2024 $ 68 $ 130,252 $ 51,004 754,815 139,148 (5,490) 1,069,797
Ending balance (in shares) at Sep. 30, 2024 67,855,084 44,301 6        
Beginning balance at Jun. 30, 2024 $ 57     721,814 221,321 (9,948) 933,244
Beginning balance (in shares) at Jun. 30, 2024 56,543,382            
Net loss         (82,174)   (82,174)
Other comprehensive income           4,458 4,458
Stock based compensation       (212)     (212)
Stock grants - vesting of restricted stock units         1   1
Stock grants - vesting of restricted stock units (in shares) 3,026            
Stock issued, value $ 11 $ 138,462   35,307     35,318
Stock issued (in shares) 11,308,676 44,301          
Issuance of warrants     $ 54,219       54,219
Issuance of warrants (in shares)     6        
Issuance costs   $ (8,210) $ (3,215) (2,094)     (13,519)
Ending balance at Sep. 30, 2024 $ 68 $ 130,252 $ 51,004 754,815 139,148 (5,490) 1,069,797
Ending balance (in shares) at Sep. 30, 2024 67,855,084 44,301 6        
Beginning balance at Dec. 31, 2024 $ 82 $ 87,649 $ 51,004 798,505 125,038 (8,915) 1,053,363
Beginning balance (in shares) at Dec. 31, 2024 82,365,388 29,811 6        
Net loss         (147,117)   (147,117)
Other comprehensive income           7,145 7,145
Stock based compensation       5,371     5,371
Stock grants - vesting of restricted stock units (in shares) 32,312            
Repurchase of shares from restricted shares vesting (in shares) (8,603)            
Conversion of preferred shares to common shares $ 1           (851)
Conversion of preferred shares to common shares (in shares) 290,000            
Converted stock in common shares (in shares)   (290)          
Converted stock in common shares   $ (852)          
Ending balance at Sep. 30, 2025 $ 83 $ 86,797 $ 51,004 803,876 (22,079) (1,770) 917,911
Ending balance (in shares) at Sep. 30, 2025 82,679,097 29,521 6        
Beginning balance at Jun. 30, 2025 $ 82 $ 87,649 $ 51,004 801,978 124,244 (14,331) 1,050,626
Beginning balance (in shares) at Jun. 30, 2025 82,386,071 29,811 6        
Net loss         (146,323)   (146,323)
Other comprehensive income           12,561 12,561
Stock based compensation       1,898     1,898
Stock grants - vesting of restricted stock units (in shares) 3,026            
Conversion of preferred shares to common shares $ 1           (851)
Conversion of preferred shares to common shares (in shares) 290,000            
Converted stock in common shares (in shares)   (290)          
Converted stock in common shares   $ (852)          
Ending balance at Sep. 30, 2025 $ 83 $ 86,797 $ 51,004 $ 803,876 $ (22,079) $ (1,770) $ 917,911
Ending balance (in shares) at Sep. 30, 2025 82,679,097 29,521 6